Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

CompletedOBSERVATIONAL
Enrollment

9,151

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Healthy
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2/Influenza/RSV RT-PCR

nasal swab

Trial Locations (1)

70121

Ochsner Clinic Foundation, New Orleans

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY